Compare ADMA & PBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADMA | PBI |
|---|---|---|
| Founded | 2004 | 1920 |
| Country | United States | United States |
| Employees | N/A | 6600 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Office Equipment/Supplies/Services |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.6B |
| IPO Year | 2012 | N/A |
| Metric | ADMA | PBI |
|---|---|---|
| Price | $9.15 | $18.31 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 3 |
| Target Price | ★ $25.67 | $13.00 |
| AVG Volume (30 Days) | ★ 3.6M | 2.9M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.29% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $42,219,783.00 | N/A |
| Revenue This Year | $27.46 | N/A |
| Revenue Next Year | $22.11 | N/A |
| P/E Ratio | $48.79 | ★ $13.24 |
| Revenue Growth | ★ 43.85 | N/A |
| 52 Week Low | $7.21 | $8.95 |
| 52 Week High | $20.46 | $18.25 |
| Indicator | ADMA | PBI |
|---|---|---|
| Relative Strength Index (RSI) | 59.64 | 66.84 |
| Support Level | $7.38 | $16.80 |
| Resistance Level | $11.42 | N/A |
| Average True Range (ATR) | 0.32 | 0.67 |
| MACD | 0.10 | -0.02 |
| Stochastic Oscillator | 84.09 | 83.78 |
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.
Pitney Bowes Inc is a technology-driven company that provides SaaS shipping solutions, mailing innovation, and financial services to clients around the globe. The company's reportable segments are SendTech Solutions and Presort Services. SendTech Solutions includes the revenue and related expenses from physical and digital mailing and shipping technology solutions, financing, services, supplies and other applications to help simplify and save on the sending, tracking and receiving of letters, parcels and flats. Presort Services includes the revenue and related expenses from sortation services to qualify large volumes of First Class Mail, Marketing Mail and Marketing Mail Flats/Bound Printed Matter for postal work sharing discounts. It derives maximum revenue from SendTech Solutions.